poison control semaglutide approval boosts GLP-1 center reports GLP-1 exposure calls to Connecticut

Are Zepbound, Semaglutide, and Wegovy FDA-approved for weight loss

This can lead to kidney failure and premature death if dialysis or a kidney transplant are unavailable

The insurance-free model delivers multiple consumer advantages in affordable weight loss programs: immediate service access without the 14-21 day prior authorization delays typical of insurance-based programs, complete privacy with no insurance claims creating employer-visible records or permanent medical history documentation accessible across healthcare systems, predictable monthly costs without co-payment variations based on deductible status or mid-year policy changes, faster prescription processing enabling treatment initiation within days rather than weeks, simplified payment through credit card rather than complex insurance claim submissions and appeals processes, elimination of coverage denial risks affecting 43%+ of insurance-based weight management service requests, and no formulary restrictions limiting medication options based on insurance company preferences

Most of these visits (69.3%) were due to severe gastrointestinal adverse reactions